Find
Dec 10, 2010

Eurex

Sanofi-Aventis: Takeover Offer to the Shareholders of Genzyme Corporation

On October 4, 2010 Sanofi-Aventis announced a takeover offer for all outstanding shares of Genzyme Corporation. Genzyme shareholders will receive a countervalue of USD 69.00 per share in cash.

Please find in the following potential impacts this transaction will have on the existing Eurex stock futures contract on shares of Genzyme Corporation (GENF).

Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.